Welcome to our dedicated page for Adm Tronics news (Ticker: ADMT), a resource for investors and traders seeking the latest updates and insights on Adm Tronics stock.
ADM Tronics Unlimited, Inc. reports operating results and product-development updates for a diversified technology developer and manufacturer trading on the OTCQB under ADMT. Company updates focus on three activity areas: proprietary electronic medical devices, design, engineering, regulatory and manufacturing services, and eco-friendly water-based formulations.
Recurring news themes include fiscal quarter and annual revenue trends, segment performance in electronics, engineering services and chemical formulations, and research and development for the Sonotron and Vet-Sonotron non-invasive musculoskeletal pain therapy technologies. Releases also cover contract engineering and manufacturing services, medical-device development, and the regulatory pathway for a human medical version of the Sonotron technology.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
ADM Tronics Unlimited, Inc. (OTCQB: ADMT) reported its third fiscal quarter results for FY 2023, highlighting a net income of $155,148 for the nine months ended December 31, 2022, a turnaround from a net loss of $140,221 a year prior. Revenues surged over 31% to $3,044,838 compared to $2,322,871 for the same period in 2021. The Electronics segment alone saw a revenue increase of over 73%. For the latest quarter, ADMT also posted a net income of $93,771, contrasting a net loss of $72,393 for the same quarter last year. The company attributes its revenue growth to all three operational segments: Electronics, Engineering, and Chemical.
ADM Tronics Unlimited (OTCQB: ADMT) reported a 27% increase in revenues for Q1 FY2023, totaling $921,408 compared to $721,358 in the prior year. Despite facing challenges from supply chain issues and increased raw material costs, the company maintained a 42% gross profit margin. R&D expenses decreased by 23%, reflecting the nearing completion of the Vet-Sonotron technology development. Loss from operations also improved, decreasing by 20% to $34,625. ADMT anticipates continued revenue growth.
ADM Tronics Unlimited, Inc. (OTCQB:ADMT) announced fiscal results for the year ending March 31, 2022, showing revenues of $3.21 million, a 4% increase from the prior year. Gross profit rose to $1.25 million, approximately 39% of revenues. Operating expenses increased to $2.38 million, leading to a net loss of $1.38 million. The company remains focused on the commercialization of its Vet-Sonotron technology despite ongoing supply chain issues. Positive future growth opportunities are anticipated from both Vet-Sonotron and the upcoming Sonotron Mark 2.